|
Pulp And Tissue Restructuring (Pulp And Tissue Restructuring [Member])
|
6 Months Ended |
|---|---|
|
Jun. 30, 2013
|
|
|
Pulp And Tissue Restructuring [Member]
|
|
| Restructuring Cost and Reserve | |
| Pulp and Tissue Restructuring | Pulp and Tissue Restructuring Actions In 2011 and 2012, we executed pulp and tissue restructuring actions in order to exit our remaining integrated pulp manufacturing operations and improve the underlying profitability and return on invested capital of our consumer tissue and KCP businesses. These actions involved the streamlining, sale or closure of six of our manufacturing facilities around the world. In conjunction with these actions, we exited certain non-strategic products, primarily non-branded offerings, and transferred some production to lower-cost facilities in order to improve overall profitability and returns. The actions were substantially complete at December 31, 2012. During the three months ended June 30, 2012, charges of $18 and $1 were recorded in cost of products sold and marketing, research and general expenses, respectively, for the restructuring actions. A related benefit of $3 was recorded in provision for income taxes. On a geographic basis, $15, $3 and $1 of the charges were recorded in the United States, Australia and other countries, respectively. During the six months ended June 30, 2012, charges of $53 and $1 were recorded in cost of products sold and marketing, research and general expenses, respectively, for the restructuring actions. A related benefit of $14 was recorded in provision for income taxes. On a geographic basis, $48, $5 and $1 of the charges were recorded in the United States, Australia and other countries, respectively. See Note 9 for additional information on the charges by segment. |